By Josh White
Date: Tuesday 19 Nov 2024
(Sharecast News) - Lung cancer diagnostics developer LungLife AI reported significant progress in the commercialisation of its 'LungLB' test on Tuesday, which was designed to facilitate early detection and improve patient outcomes.
By Josh White
Date: Friday 16 Aug 2024
(Sharecast News) - Lung cancer diagnostic technology developer LungLife AI announced the finalisation of Medicare coverage for its molecular risk-stratification test, LungLB, aimed at evaluating indeterminate pulmonary nodules, on Friday.
No recent information was found.
Currency | UK Pounds |
Share Price | 8.75p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 90.00 |
52 Week Low | 8.25 |
Volume | 35,000 |
Shares Issued | 25.49m |
Market Cap | £2.23m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
08:05 | 12,500 @ 8.75p |
08:00 | 12,500 @ 8.75p |
You are here: research